Grant received in 2022
DCCC has funded 200,000 DKK to the project
Precision Medicine is treatment adapted to the individual patient based on genetic information. Presently, patients with treatment refractory cancer is offered comprehensive genomic analysis in order to inform choice of treatment. Due to the complexity in analysing, interpretation and clinical implementation of comprehensive genomic analyses, national collaboration is crusial in order to ensure a common national procedure.
Collaboration with relevant disciplines, bioinformatic analyses, variant interpretation, and clinical implementation, takes part partly though ”Network for harmonization of somatic variant interpretation for treatment purposes for patients with treatment refractory cancer”.
The founding of the network was supported by DCCC in 2018 and is now well established. The aim of the present application is to ensure continued activities within the network.
Multidisciplinary organisation
Anchored in a well-established collaboration center around the National Tumor Board / Genomic MDT as well as it national treatment study ProTarget
Project stakeholder
North Jutland Region / Aalborg University Hospital (AAUH) / Aalborg University (AU):
- Inge Søkilde, Professor, Department of Molecular Diagnostics, AAUH / AAU
- Morten Ladekarl, Professor, Chief Physician, Department of Oncology, AAUH / AAU
- Martin Bøgsted, Professor, Department of Clinical Medicine, AAU / Head of DCBIG (Danish Bioinformatics Group)
Central Region / Aarhus University Hospital (AUH) / Aarhus University (AU):
- Anders Bojesen, Chief Physician, Department of Clinical Genetics, AUH
- Professor, Chief Physician Torben Steinicke, Department of Pathology, AUH / Clinical Department, AU Professor,
- Chief Physician Henrik Hasle, Department of Pediatrics, AUH / Clinical Department, AU
- Britt Elmedal Laursen, chief physician, associate professor, MOMA / Department of Cancer, AUH / Department of Biomedicine, AU. Primary contact, e-mail: britt@biomed.au.dk
- Ole Halfdan Larsen, chief physician, MOMA, AUH / Clinical Department, AU
- Eva Aggerholm Sædder, Chief Physician, Department of Clinical Pharmacology, AUH / Department of Biomedicine, AU
- Anni Ravnsbæk Jensen, chief physician, Department of Cancer, AUH. Region of Southern Denmark / University of Southern Denmark (SDU)
- Lars Henrik Jensen, chief physician, Department of Oncology, Vejle Hospital
- Mette Warming Jørgensen, Chief Physician, Clinical Genetics, Vejle
- Karin Holmskov, Chief Physician, Department of Oncology, OUH / SDU
- Thomas Kielsgaard Kristensen, Head of Function, Department of Clinical Pathology, OUH / SDU.
The Capital Region of Denmark / Rigshospitalet (RH) / Herlev Hospital / University of Copenhagen (KU):
- Finn Cilius Nielsen, Chief Medical Officer, Professor, Department of Genomic Medicine, RH / KU
- Kristoffer Rohrberg, chief physician, head of the Phase 1 Unit, RH
- Ulrik Lassen, Center Manager, Department of Oncology, RH
- Rikke Eefsen, Chair Nordic NECT at the Nordic Network of Early Clinical Trials, Herlev / KU
- Estrid Høgdall, Clinical Professor, Head of Department, Molecular Unit, Department of Pathology, Herlev / KU
National Genome Center (NGC):
- Ole Lund, Head of Department, NGC